Your browser does not allow JavaScript!
Javascript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Association of NAT2 polymorphisms with type 2 diabetes in a population from Bosnia and Herzegovina
Semiz, Sabina
(
Author
),
Dujić, Tanja
(
Author
),
Ostanek, Barbara
(
Author
),
Velija-Asimi, Zelija
(
Author
),
Prnjavorac, Besim
(
Author
),
Bego, T.
(
Author
),
Malenica, M.
(
Author
),
Mlinar, Barbara
(
Author
),
Heljić, Bećir
(
Author
),
Marc, Janja
(
Author
),
Čaušević, A.
(
Author
)
URL - Presentation file, Visit
http://www.sciencedirect.com/science/article/pii/S0188440911001299
Abstract
Background and Aims N-acetyltransferase 2 (NAT2) is a drug-metabolizing enzyme, which is genetically variable in human populations. Polymorphisms in the NAT2 gene have been associated with drug efficacy and toxicity as well as disease susceptibility. Recently, an association of NAT2 gene variation with risk of type 2 diabetes mellitus (T2DM) has been suggested. This is the first study performed in a population from Bosnia and Herzegovina (BH) in which the frequency of two common NAT2 polymorphisms, 341T>C (NAT2*5) and 590G>A (NAT2*6) was determined in diabetic patients. Methods The frequency of the NAT2*5 (341T>C) and NAT2*6 (590G>A) polymorphisms was analyzed by employing TaqMan SNP Genotyping Assays (Applied Biosystems) in a group of 63 patients with T2DM and 79 nondiabetic subjects. Results Our data demonstrated that the frequencies of NAT2*5 (341T>C) and NAT2*6 (590G>A) polymorphisms in BH population were in line with the Caucasians genotype data. The NAT2*5 and NAT2*6 alleles were in high linkage disequilibrium (D? = 0.969). Strinkingly, there was a significant difference in genotype frequencies for NAT2*5 (p <0.05) and NAT2*6 (p <0.001) polymorphisms between diabetic and nondiabetic subjects. NAT2*5 polymorphism was associated with 2.4-fold increased risk for developing T2DM (adjusted OR = 2.40, 95% CI = 1.10-5.25, p = 0.028). On the contrary, NAT2*6 variant significantly decreased by 5-fold susceptibility to the disease (adjusted OR = 0.20, 95% CI = 0.09-0.43, p <0.001). Conclusions Our data demonstrated that NAT2 genetic variation appeared to be an important risk factor in development of T2DM.
Language:
English
Keywords:
N-acetiltransferaza
,
diabetes tipa 2
,
polimorfizem
,
NAT2*5
,
NAT2*6
Work type:
Not categorized (r6)
Tipology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
Year:
2011
Number of pages:
str. 311-317
Numbering:
Vol. 42, iss. 4
UDC:
577
ISSN on article:
0188-4409
COBISS.SI-ID:
3064177
Views:
718
Downloads:
256
Metadata:
Average score:
(0 votes)
Your score:
Voting is allowed only to
logged in
users.
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Share:
AddThis uses cookies that require your consent.
Edit consent...
Record is a part of a journal
Title:
Archives of medical research
Shortened title:
Arch. med. res.
Publisher:
Subjefatura de Investigación. IMSS
ISSN:
0188-4409
COBISS.SI-ID:
508181
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Comments
Leave comment
You have to
log in
to leave a comment.
Comments (0)
0 - 0 / 0
There are no comments!
Back